These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 19410949)

  • 1. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review.
    Yilmaz T; Weaver CD; Gallagher MJ; Cordero-Coma M; Cervantes-Castaneda RA; Klisovic D; Lavaque AJ; Larson RJ
    Ophthalmology; 2009 May; 116(5):902-11; quiz 912-3. PubMed ID: 19410949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis.
    Qi HP; Bi S; Wei SQ; Cui H; Zhao JB
    Curr Eye Res; 2012 Dec; 37(12):1136-47. PubMed ID: 22793880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema.
    Yilmaz T; Cordero-Coma M; Gallagher MJ; Teasley LA
    Acta Ophthalmol; 2011 Dec; 89(8):709-17. PubMed ID: 20645926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema.
    Gillies MC; Simpson JM; Gaston C; Hunt G; Ali H; Zhu M; Sutter F
    Ophthalmology; 2009 Nov; 116(11):2182-7. PubMed ID: 19796823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Efficacy of Sub-Tenon versus Intravitreal Triamcinolone Acetonide Injection during Cataract Surgery for Diabetic Macular Edema.
    Tatsumi T; Oshitari T; Ando T; Takatsuna Y; Arai M; Baba T; Sato E; Yamamoto S
    Ophthalmologica; 2019; 241(1):17-23. PubMed ID: 30041252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema.
    Lee HY; Lee SY; Park JS
    Korean J Ophthalmol; 2009 Sep; 23(3):153-8. PubMed ID: 19794940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal triamcinolone for diabetic macular edema: comparison of 1, 2, and 4 mg.
    Hauser D; Bukelman A; Pokroy R; Katz H; Len A; Thein R; Parness-Yossifon R; Pollack A
    Retina; 2008 Jun; 28(6):825-30. PubMed ID: 18536598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema.
    Kim JE; Pollack JS; Miller DG; Mittra RA; Spaide RF;
    Retina; 2008 May; 28(5):735-40. PubMed ID: 18463518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of intravitreal triamcinolone acetonide in diabetic macular edema refractory to anti-VEGF treatment.
    Hong IH; Choi W; Han JR
    Jpn J Ophthalmol; 2020 Mar; 64(2):196-202. PubMed ID: 31900869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
    Batioğlu F; Ozmert E; Parmak N; Celik S
    Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of changes in retinal thickness and visual acuity after intravitreal triamcinolone acetonide for diffuse diabetic macular edema with and without previous macular laser treatment.
    Patelli F; Fasolino G; Radice P; Russo S; Zumbo G; DI Tizio FM; Frisone G; Marchi S
    Retina; 2005; 25(7):840-5. PubMed ID: 16205561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intravitreal preservative-free triamcinolone versus posterior sub-tenon triamcinolone acetonide injection for bevacizumab-resistant diabetic macular edema.
    Jeon SH; Kim M; Roh YJ
    BMC Ophthalmol; 2024 Jan; 24(1):25. PubMed ID: 38243166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of postvitrectomy intravitreal triamcinolone therapy for diabetic macular edema.
    Costa JF; Sousa K; Marques JP; Marques M; Cachulo ML; Silva R; Gomes N; Figueira J
    Eur J Ophthalmol; 2016 Aug; 26(5):485-90. PubMed ID: 26951531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
    Kim MW; Moon H; Yang SJ; Joe SG
    Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone acetonide as primary treatment for diffuse diabetic macular edema: a prospective noncomparative interventional case series.
    Nicolò M; Nasciuti F; Lai S; Ghiglione D; Borgia L; Calabria G
    Eur J Ophthalmol; 2006; 16(1):129-33. PubMed ID: 16496256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study.
    Brasil OF; Smith SD; Galor A; Lowder CY; Sears JE; Kaiser PK
    Br J Ophthalmol; 2007 Jun; 91(6):761-5. PubMed ID: 17108013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal steroids for macular edema in diabetes.
    Grover D; Li TJ; Chong CC
    Cochrane Database Syst Rev; 2008 Jan; (1):CD005656. PubMed ID: 18254088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
    Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA
    Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.